Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models

European Journal of Pharmacology

Volumn 506, Issue 3, 2005, Pages 257-264

  Orzechowski, Raymond F ^a   Currie, Debra S ^a,b   Valancius, Cathryn A ^a  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Acetylcholine; Anticholinergic; Antihistamine; Carbachol; Histamine H1 antagonist

Indexed keywords

ATROPINE; CARBACHOL; CETIRIZINE; CHLORPHENIRAMINE MALEATE; CYPROHEPTADINE; DESLORATADINE; DIPHENHYDRAMINE; FEXOFENADINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; LORATADINE; MEPYRAMINE MALEATE; PROMETHAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST;

ANESTHESIA; ANIMAL MODEL; ANTICHOLINERGIC EFFECT; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG EFFECT; GUINEA PIG; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TRACHEA MUSCLE; ANIMAL; BLOOD PRESSURE; COMPARATIVE STUDY; DOSE RESPONSE; IN VITRO STUDY; MUSCLE CONTRACTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PRESSURE; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HISTAMINE H1 ANTAGONISTS; MALE; MUSCLE CONTRACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H1;

EID: 14944341738     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.11.006     Document Type: Article

References (27)

1. T. Abe, T. Omata, K. Yoshida, T. Matsumura, Y. Ikeda, Y. Segawa, K. Matsuda, and H. Nagai Antiallergic effect of ZCR-2060: antihistaminic action Jpn. J. Pharmacol. 66 1994 87 94
2. A.D Arunlakshana, and H.O. Schild Some quantitative uses of drug antagonists Br. J. Pharmacol. 14 1959 48 54
3. N.J. Brown, and L.J. Roberts II Histamine, bradykinin, and their antagonists J.G. Hardman L.E. Limbird Goodman and Gilman's Pharmacological Basis of Therapeutics 10th ed. 2001 McGraw Hill New York, NY 656
4. I. Cardelús, F. Antón, J. Beleta, and J. Palacios Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle Eur. J. Pharmacol. 374 1999 249 254
5. B.B. Carlson, J.T. Trevitt, and J.D. Salamone Effects of H1 antagonists on cholinomimetics-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine Pharmacol. Biochem. Behav. 65 2000 683 689
6. R.M. Eglen, S.S. Hegde, and N. Watson Muscarinic receptor subtypes and smooth muscle function Pharmacol. Rev. 48 1996 531 565
7. J. Ellis, and M. Seidenberg Desloratadine interacts with muscarinic acetylcholine receptors with high affinity and antagonizes the cyclic AMP response at the M2 subtype J. Allergy Clin. Immunol. 107 2001 S160 (abstract 528)
8. M. Eltze, B. Ullrich, E. Mutschler, U. Moser, E. Bungardt, T. Friebe, C. Gubitz, R. Tacke, and G. Lambrecht Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney Eur. J. Pharmacol. 238 1993 343 355
9. E.B. Haddad, Y. Landry, and J.P. Gies Muscarinic receptor subtypes in guinea pig airways Am. J. Physiol. 261 1991 L327 L333
10. M.G. Hendriks, M. Pfaffendorf, and P.A. Van Zwieten Characterization of the muscarinic receptor subtype mediating vasodilation in the rat perfused mesenteric vascular bed preparation J. Auton. Pharmacol. 12 1992 411 420
11. 3[H]mepyramine binding and from inhibition of a functional response J. Neurochem. 37 1981 1357 1360
12. I. Hindmarch, and Z. Shamsi Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects Clin. Exp. Allergy 29 1999 133 142
13. 1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects Arzneim.-Forsch. Drug Res. 50 2000 345 352
14. N. Kubo, O. Shirakawa, T. Kuno, and C. Tanaka Antimuscarinic effect of antihistamines: quantitative evaluation by receptor binding assay Jpn. J. Pharmacol. 43 1987 277 282
15. 1-receptors Jpn. J. Pharmacol. 27 1977 491 500
16. D.G. McCormack, J.C. Mak, P. Minette, and P.J. Barnes Muscarinic receptor subtypes mediating vasodilation in the pulmonary artery Eur. J. Pharmacol. 158 1988 293 297
17. C.J.E. Niemegeers, F.H.L. Awouters, and P.A.J. Janssen The in vivo pharmacologic profile of histamine (H1) antagonists in the rat Drug Dev. Res. 2 1982 559 566
18. C.J. Niemegeers, F. Awouters, F.M. Lenaerts, J. Vermeire, and P.A. Janssen Prevention of physostigmine-induced lethality in rats. A pharmacological analysis Arch. Int. Pharmacodyn. Ther. 259 1982 153 165
19. X. Norel, L. Walch, M. Costantino, C. Labat, I. Gorenne, E. Dulmet, F. Rossi, and C. Brink M1 and M3 muscarinic receptors in human pulmonary arteries Br. J. Pharmacol. 119 1996 149 157
20. D.C. Remy, K.E. Rittle, C.A. Hunt, P.S. Anderson, E.L. Engelhardt, B.V. Clineschmidt, and A. Scriabine (+)- and (-)-3-methoxycyproheptadine. A comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadine J. Med. Chem. 20 1977 1681 1684
21. J.J. Reuse Comparisons of various histamine antagonists Br. J. Pharmacol. 3 1948 174 179
22. Z. Shamsi, and I. Hindmarch Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios Hum. Psychopharmacol. Clin. Exp. 15 2000 S3 S30
23. T.R. Sherrod, E.R. Loew, and H.F. Schloemer Pharmacological properties of antihistamine drugs, benadryl, pyribenzamine, and neoantergan J. Pharmacol. Exp. Ther. 89 1947 247 255
24. F.E.R. Simons Non-cardiac adverse effects of antihistamines (H1-receptor antagonists) Clin. Exp. Allergy 29 Suppl. 3 1999 125 132
25. J.W. Slater, A.D. Zechnich, and D.G. Haxby Second-generation antihistamines: a comparative review Drugs 57 1999 31 47
26. A.M. Ter Laak, G.M. Donne-Op den Kelder, A. Bast, and H. Timmerman Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study Eur. J. Pharmacol. 232 1993 199 205
27. L. Walch, X. Norel, B. Leconte, J.P. Gascard, and C. Brink Cholinergic control of human and animal pulmonary vascular tone Therapie 54 1999 99 102